Dermatology and Therapy (May 2024)
Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)
- A. Pinter,
- A. Costanzo,
- S. Khattri,
- S. D. Smith,
- J. M. Carrascosa,
- Y. Tada,
- E. Riedl,
- A. Reich,
- A. Brnabic,
- N. Haustrup,
- A. Lampropoulou,
- I. Lipkovich,
- Z. Kadziola,
- C. Paul,
- C. Schuster
Affiliations
- A. Pinter
- University Hospital Frankfurt
- A. Costanzo
- Division of Dermatology, Humanitas Research Hospital
- S. Khattri
- Icahn School of Medicine at Mount Sinai
- S. D. Smith
- ANU Medical School, ANU College of Health and Medicine, The Australian National University
- J. M. Carrascosa
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma of Barcelona, IGTP
- Y. Tada
- Department of Dermatology, Teikyo University School of Medicine
- E. Riedl
- Department of Dermatology, Medical University of Vienna
- A. Reich
- Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University
- A. Brnabic
- Eli Lilly and Company
- N. Haustrup
- Eli Lilly and Company
- A. Lampropoulou
- Eli Lilly and Company
- I. Lipkovich
- Eli Lilly and Company
- Z. Kadziola
- Eli Lilly and Company
- C. Paul
- Université Paul Sabatier Toulouse III
- C. Schuster
- Department of Dermatology, Medical University of Vienna
- DOI
- https://doi.org/10.1007/s13555-024-01105-3
- Journal volume & issue
-
Vol. 14,
no. 6
pp. 1495 – 1496
Abstract
No abstracts available.
